Feb 1 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 9 points
higher at 6,417 on Monday, according to financial bookmakers.
* RYANAIR: Ryanair RYA.I said it may lose close to 1 billion euros in its
current financial year, by far its worst ever performance, but Europe's largest
low-cost carrier said the crisis would create significant growth
opportunities. * ASOS: ASOS ASOS.L is on the verge of a deal to buy Topshop and Miss
Selfridge from the administrators of British tycoon Philip Green's Arcadia Group
for almost 300 million pounds, Sky News reported. * ASTRAZENECA: The European Commission gave approval on Friday for the use
of the COVID-19 vaccine developed by AstraZeneca, the final step to allowing
Europe to use it across the continent.
* CAIRN ENERGY: The Indian government may give Cairn Energy CNE.L a
surrendered oil field such as the Ratna R-Series in lieu of an arbitration award
against the South Asian country, according to a Press Trust of India report in
financial daily Mint. * COVID-19: EU officials confessed on Saturday to a "blunder" in invoking
Northern Ireland Brexit emergency powers during a showdown with Britain over
vaccines, and London said it expected its supply of COVID-19 shots would not be
interrupted. * SILVER: Silver rallied for a third straight session, soaring as much as
7.4% to a near six-month peak, after social media posts since last week called
for retail investors to flood into the market. * OIL: Oil prices edged higher after a weak start, holding on to the past
three months of gains, although patchy coronavirus vaccine rollouts, new
infections and the discovery of new variants are keeping a lid on
prices. * The UK blue-chip index .FTSE closed 1.8% lower on Friday as stalled
vaccine rollouts and lockdowns to curb the spread of contagious new coronavirus
variants kept investors from jumping into riskier assets. UK CORPORATE DIARY:
Hargreaves Lansdown Plc HRGV.L HY results
* For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB